Alembic Pharma Gets USFDA Nod for Cancer Drug; Shares End Flat
January 12, 2026January 12, 2026 Shares of Alembic Pharmaceuticals Ltd ended flat after touching a day’s high of Rs 804.15 on 12th January, even as the company said it had received tentative approval from the US Food and Drug Administration (USFDA) for its Bosutinib Tablets, 400 mg. In a…